Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,423,174
+$45,522 QoQ
Shares Held
9,081
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#517
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026May Hill Capital, LLC holds $9,985,779 across 14 Drug Manufacturers - General names. NVS ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,758 | $2,108,598 | |
| 2 | NVS |
Novartis AG
This page
|
9,081 | $1,423,174 | |
| 3 | JNJ |
Johnson & Johnson
|
5,392 | $1,369,406 | |
| 4 | ABBV |
AbbVie Inc.
|
4,097 | $1,030,969 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,298 | $937,793 | |
| 6 | NVO |
Novo Nordisk A S
|
14,529 | $696,520 | |
| 7 | GSK |
GSK plc
|
9,997 | $524,042 | |
| 8 | AZN |
Astrazeneca PLC
|
2,535 | $480,686 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,423,174 | 9,081 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,377,652 | 9,019 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,049,880 | 7,615 | Shares | Sole | 2026-05-07 | |
| 2025-09-30 | $962,441 | 7,505 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $759,216 | 6,274 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $467,101 | 4,190 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $265,072 | 2,724 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||